General Information of This Antibody
Antibody ID
ANI0YCMBJ
Antibody Name
Anti-CD24 G7mAb
Antibody Type
Anti-CD24 G7mAb
Antibody Subtype
Humanized IgG1-kappa
Antigen Name
Signal transducer CD24 (CD24)
 Antigen Info 
Click to Show/Hide the Sequence Information of This Antibody
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
HN-01 [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Tumor Growth Inhibition value (TGI) ≈ 81.30% Positive CD24 expression (CD24 +++/++)
Method Description
A hepatocellular carcinoma xenograft model was established by subcutaneously injecting BEL-7402 cells (1 x 107) into right flanks of BALB/c nude mice. When the average tumor volume reached 100 mm3, tumor-bearing mice were divided randomly into seven groups (six mice/group) and treated with HN-01 (10 mg/kg) every 3 days.
In Vivo Model BEL-7402 CDX model
In Vitro Model Hepatoma Bel-7402 cells CVCL_5492
References
Ref 1 Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma. Cancer Res. 2019 Jul 1;79(13):3395-3405. doi: 10.1158/0008-5472.CAN-18-2839. Epub 2019 Mar 27.